Phase 0 1 trial
Phase 0
NCT05343572 Nov 2023 → Dec 2026 expected Asherman syndrome , infertility disorder , uterine disorder Hugh Taylor
Recruiting
No outcome recorded
Phase 1 24 trials
Phase 1
NCT07585136 Nov 2026 → Dec 2028 expected bone marrow failure syndrome St. Jude Children's Research Hospital
Recruiting
No outcome recorded
Phase 1
NCT03932864 Apr 2019 → Feb 2020 —
Ensoma
Completed
No outcome recorded
Phase 1
NCT03664830 Sep 2018 → Jul 2027 expected sickle cell disease City of Hope Medical Center
Active not recruiting
No outcome recorded
Phase 1
NCT03226691 Jul 2017 → Feb 2019 sickle cell disease National Heart, Lung, and Blood Institute (NHLBI)
Completed
No outcome recorded
Phase 1
NCT03277209 Jul 2017 → Dec 2019 malignant pancreatic neoplasm Weill Medical College of Cornell University
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT02989701 Jan → Dec 2017 sickle cell disease Alessandra Biffi
Completed
No outcome recorded
Phase 1
NCT02179970 Jun 2015 → Dec 2018 colorectal cancer , ovarian serous adenocarcinoma , pancreatic adenocarcinoma CCTU- Cancer Theme
Completed
No outcome recorded
Phase 1
NCT02193191 Sep 2014 → Mar 2025 sickle cell disease Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1
NCT01916577 Aug 2013 → Oct 2017 chronic obstructive pulmonary disease , cystic fibrosis , pulmonary fibrosis University of Colorado, Denver
Completed
No outcome recorded
Phase 1
NCT01610999 Jul 2013 → Jun 2014 B-cell chronic lymphocytic leukemia , plasma cell myeloma Tufts Medical Center
Terminated
No outcome recorded
Phase 1
NCT01711073 Oct 2012 → Sep 2013 liver failure Proteonomix, Inc.
Unknown
No outcome recorded
Phase 1
NCT01373229 Jan 2012 → Mar 2014 B-cell chronic lymphocytic leukemia David Rizzieri, MD
Completed
No outcome recorded
Phase 1
NCT01455025 Jan 2012 → Mar 2015 acute myeloid leukemia French Innovative Leukemia Organisation
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT01339039 Dec 2011 → Apr 2014 anaplastic astrocytoma , anaplastic oligoastrocytoma , anaplastic oligodendroglioma , gliosarcoma Patrick Y. Wen, MD
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT01579149 Sep 2011 → Feb 2012 —
Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 1
NCT01319864 Mar 2011 → Jun 2013 acute leukemia of ambiguous lineage , precursor lymphoblastic lymphoma/leukemia , therapy related acute myeloid leukemia and myelodysplastic syndrome Seattle Children's Hospital
Completed
No outcome recorded
Phase 1
NCT01058993 Oct 2010 → Mar 2011 neutropenia University of Washington
Completed
No outcome recorded
Phase 1
NCT01065129 Sep 2010 → Jul 2014 myelodysplastic syndrome Washington University School of Medicine
Completed
No outcome recorded
Phase 1
NCT01068301 May 2010 → Oct 2013 acute lymphoblastic leukemia , acute myeloid leukemia , chronic myeloid leukemia , myelodysplastic syndrome St. Jude Children's Research Hospital
Completed
No outcome recorded
Phase 1
NCT01027923 May → Jul 2010 acute myeloid leukemia Washington University School of Medicine
Terminated
No outcome recorded
Phase 1
NCT01074060 Apr 2010 → Feb 2013 plasma cell myeloma City of Hope Medical Center
Completed
No outcome recorded
Phase 1
NCT00990054 Dec 2009 → Mar 2012 acute myeloid leukemia Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 1
NCT00694590 Jun 2008 → Nov 2010 chronic lymphocytic leukemia/small lymphocytic lymphoma Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 1
NCT00445302 Jan 2006 → Aug 2007 impaired renal function disease Genzyme, a Sanofi Company
Completed
No outcome recorded
Show 14 more trials Phase 1/2 15 trials · 2 met primary
Phase 1/2
NCT07341022 Jun 2026 → Dec 2027 expected sickle cell disease Hospital Israelita Albert Einstein
Not yet recruiting
No outcome recorded
Phase 1/2
NCT05470491 Jan 2023 → Jul 2027 expected HIV infectious disease , hematopoietic and lymphoid cell neoplasm National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 1/2
NCT03182426 Aug 2017 → Jul 2024 type 1 diabetes mellitus University of Alberta
Completed
No outcome recorded
Phase 1/2
NCT02678533 Feb 2017 → Nov 2018 Fanconi anemia Assistance Publique - Hôpitaux de Paris
Completed
No outcome recorded
Phase 1/2
NCT02212535 Jan 2016 → Apr 2017 sickle cell disease Assistance Publique - Hôpitaux de Paris
Completed
No outcome recorded
Phase 1/2
NCT02522572 Aug 2015 → Sep 2020 —
E. Steve Woodle
Unknown
No outcome recorded
Phase 1/2
NCT01977677 Nov 2014 → Nov 2017 adult glioblastoma , adult medulloblastoma , adult pineoblastoma , ependymoblastoma +4 Lawrence Recht
Completed
No outcome recorded
Phase 1/2
NCT01288573 Mar 2014 → May 2017 brain neoplasm , neuroblastoma , sarcoma Genzyme, a Sanofi Company
Completed
Met primary
Phase 1/2
NCT01435343 Jul 2012 → May 2016 acute myeloid leukemia PETHEMA Foundation
Completed
No outcome recorded
Phase 1/2
NCT01280955 Dec 2011 → Sep 2014 bone marrow failure syndrome Mitchell Horwitz, MD
Completed
Met primary
Phase 1/2
NCT01236144 Apr 2011 → Dec 2013 acute myeloid leukemia , myelodysplastic syndrome Cardiff University
Completed
No outcome recorded
Phase 1/2
NCT00906945 Feb 2011 → Nov 2012 acute myeloid leukemia Washington University School of Medicine
Completed
No outcome recorded
Phase 1/2
NCT01160354 Aug 2010 → Mar 2016 acute myeloid leukemia M.D. Anderson Cancer Center
Terminated
No outcome recorded
Stop: Enrollment
Phase 1/2
NCT00903968 Jun 2009 → Jun 2016 plasma cell myeloma Dana-Farber Cancer Institute
Completed
No outcome recorded
Phase 1/2
NCT00822770 Jan 2009 → Oct 2012 disease related to hematopoietic stem cell transplant , leukemia M.D. Anderson Cancer Center
Completed
No outcome recorded
Show 5 more trials Phase 2 48 trials · 2 met primary
Phase 2
NCT07188090 Oct 2025 → Dec 2027 expected Hodgkins lymphoma , non-Hodgkin lymphoma , plasma cell myeloma Thomas Jefferson University
Recruiting
No outcome recorded
Phase 2
NCT06872333 Nov 2024 → Jun 2030 expected disease related to hematopoietic stem cell transplant , sickle cell disease Masonic Cancer Center, University of Minnesota
Recruiting
No outcome recorded
Phase 2
NCT06141304 Sep 2023 → Jan 2025 acute myeloid leukemia , adult acute lymphoblastic leukemia The First Hospital of Jilin University
Unknown
No outcome recorded
Phase 2
NCT04817345 Apr 2023 sickle cell disease St. Jude Children's Research Hospital
Withdrawn
No outcome recorded
Stop: Enrollment
Phase 2
NCT05411575 Jul → Oct 2022 COVID-19 , acute respiratory distress syndrome 4Living Biotech
Withdrawn
No outcome recorded
Stop: Enrollment
Phase 2
NCT05445128 Jun → Dec 2022 sickle cell disease Ensoma
Terminated
No outcome recorded
Stop: Business
Phase 2
NCT04762875 Jun → Sep 2021 acute lymphoblastic leukemia , acute myeloid leukemia , myelodysplastic syndrome Ensoma
Terminated
No outcome recorded
Stop: Business
Phase 2
NCT04177810 Nov 2020 → Mar 2023 malignant pancreatic neoplasm Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
No outcome recorded
Phase 2
NCT04552743 Oct 2020 → Jul 2021 plasma cell myeloma Surbhi Sidana, MD
Completed
Met primary
Phase 2
NCT04362293 Apr 2020 → Jun 2026 overdue sickle cell disease St. Jude Children's Research Hospital
Active not recruiting
No outcome recorded
Phase 2
NCT03547830 Apr 2019 → Jan 2023 chronic granulomatous disease Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Unknown
No outcome recorded
Phase 2
NCT03746080 Dec 2018 → May 2022 gliosarcoma , mixed neuronal-glial tumor , oligodendroglial tumor Lawrence D Recht
Completed
No outcome recorded
Phase 2
NCT03244930 May 2017 → May 2018 Hodgkins lymphoma , disease related to hematopoietic stem cell transplant , non-Hodgkin lymphoma , plasma cell myeloma Hospital Universitario Dr. Jose E. Gonzalez
Unknown
No outcome recorded
Phase 2
NCT02790957 Jun 2016 → Aug 2019 diabetes mellitus , limb ischemia Gian Paolo Fadini
Terminated
No outcome recorded
Phase 2
NCT03019809 Jun 2016 → Dec 2018 Wiskott-Aldrich syndrome , disease related to hematopoietic stem cell transplant , transplant rejection Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Unknown
No outcome recorded
Phase 2
NCT02221492 Nov 2014 → Mar 2016 lymphoma Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 2
NCT02221479 Oct 2014 → Jul 2015 plasma cell myeloma Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 2
NCT02200380 Jul 2014 → Mar 2016 B-cell chronic lymphocytic leukemia , Hodgkins lymphoma , acute myeloid leukemia , chronic myeloid leukemia +1 Celldex Therapeutics
Terminated
No outcome recorded
Phase 2
NCT02605460 Feb 2014 → Nov 2020 acute lymphoblastic leukemia , acute myeloid leukemia National Institute of Medical Sciences and Nutrition Salvador Zubiran
Unknown
No outcome recorded
Phase 2
NCT02015013 Jan 2014 → Oct 2030 expected idiopathic CD4-positive T-lymphocytopenia National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
No outcome recorded
Phase 2
NCT01954914 Dec 2013 → Jan 2016 bone marrow failure syndrome Technical University Dresden
Completed
No outcome recorded
Phase 2
NCT01818284 Oct 2013 → Jun 2016 disease related to hematopoietic stem cell transplant M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 2
NCT02931071 Sep 2013 → Oct 2018 Fanconi anemia Hospital Universitari Vall d'Hebron Research Institute
Completed
No outcome recorded
Phase 2
NCT01753453 Jun 2013 → Sep 2016 plasma cell myeloma Sanofi
Completed
No outcome recorded
Phase 2
NCT01696461 May 2013 → Aug 2016 Hodgkins lymphoma , acute myeloid leukemia , chronic lymphocytic leukemia/small lymphocytic lymphoma , chronic myeloid leukemia +1 Center for International Blood and Marrow Transplant Research
Completed
Met primary
Phase 2
NCT01547806 Feb 2012 → Jun 2014 plasma cell myeloma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01158118 Apr 2011 → Jan 2014 B-cell chronic lymphocytic leukemia , Hodgkins lymphoma , acute myeloid leukemia , myelodysplastic syndrome +1 Washington University School of Medicine
Completed
No outcome recorded
Phase 2
NCT01339572 Apr 2011 → Nov 2015 non-Hodgkin lymphoma , plasma cell myeloma University of Florida
Completed
No outcome recorded
Phase 2
NCT01097057 Nov 2010 → Sep 2013 non-Hodgkin lymphoma Fred Hutchinson Cancer Center
Completed
No outcome recorded
Phase 2
NCT01225419 Sep 2010 → May 2011 childhood malignant neoplasm University Hospital, Clermont-Ferrand
Completed
No outcome recorded
Phase 2
NCT01182675 Aug 2010 → Sep 2013 severe combined immunodeficiency University of California, San Francisco
Terminated
No outcome recorded
Phase 2
NCT01149863 Jun 2010 → Dec 2011 —
Emory University
Completed
No outcome recorded
Phase 2
NCT01164345 Jun 2010 → May 2015 Hodgkins lymphoma , non-Hodgkin lymphoma Sheba Medical Center
Completed
No outcome recorded
Phase 2
NCT01220375 Apr 2010 → Jan 2012 plasma cell myeloma Insel Gruppe AG, University Hospital Bern
Completed
No outcome recorded
Phase 2
NCT01095757 Mar 2010 → May 2012 plasma cell myeloma Emory University
Completed
No outcome recorded
Phase 2
NCT01037517 Jan 2010 → Aug 2013 plasma cell myeloma CancerCare Manitoba
Completed
No outcome recorded
Phase 2
NCT00998049 Dec 2009 → Nov 2011 plasma cell myeloma Mayo Clinic
Completed
No outcome recorded
Phase 2
NCT00901225 May 2009 → Aug 2010 Hodgkins lymphoma , non-Hodgkin lymphoma , plasma cell myeloma Duke University
Completed
No outcome recorded
Phase 2
NCT00665314 Nov 2007 → Apr 2008 Hodgkins lymphoma , non-Hodgkin lymphoma , plasma cell myeloma Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 2
NCT00444912 Feb 2006 → Jun 2009 Hodgkins lymphoma , non-Hodgkin lymphoma Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 2
NCT00396331 Oct 2005 → Dec 2009 disease related to hematopoietic stem cell transplant Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 2
NCT00395967 Apr → Jul 2005 non-Hodgkin lymphoma , plasma cell myeloma Genzyme, a Sanofi Company
Terminated
No outcome recorded
Stop: Enrollment
Phase 2
NCT00396266 Jan 2005 → Dec 2007 non-Hodgkin lymphoma , plasma cell myeloma Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 2
NCT00396201 Nov 2004 → Oct 2006 Hodgkins lymphoma Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 2
NCT00396383 Nov 2004 → May 2007 plasma cell myeloma Genzyme, a Sanofi Company
Terminated
No outcome recorded
Phase 2
NCT00322842 Sep 2004 → Feb 2007 non-Hodgkin lymphoma , plasma cell myeloma Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 2
NCT00322387 Apr 2004 → Jul 2006 non-Hodgkin lymphoma , plasma cell myeloma Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 2
NCT00322491 Mar 2004 → Jun 2006 non-Hodgkin lymphoma , plasma cell myeloma Genzyme, a Sanofi Company
Completed
No outcome recorded
Show 38 more trials Phase 3 6 trials · 2 met primary · 1 missed
Phase 3
NCT01767714 Apr 2013 → Nov 2014 non-Hodgkin lymphoma Sanofi
Completed
No outcome recorded
Phase 3
NCT01301963 Jul 2011 → Jun 2013 refractory plasma cell neoplasm Case Comprehensive Cancer Center
Terminated
No outcome recorded
Stop: Enrollment
Phase 3
NCT01146834 Mar 2011 → Feb 2019 plasma cell myeloma Weill Medical College of Cornell University
Completed
Missed primary
Phase 3
NCT00838357 Sep 2008 → Nov 2010 disease related to transplantation , non-Hodgkin lymphoma Genzyme, a Sanofi Company
Completed
No outcome recorded
Phase 3
NCT00103662 Jan 2005 → Oct 2006 plasma cell myeloma Genzyme, a Sanofi Company
Completed
Met primary
Phase 3
NCT00103610 Jan 2005 → Jul 2006 non-Hodgkin lymphoma Genzyme, a Sanofi Company
Completed
Met primary
Phase 4 4 trials · 1 missed
Phase 4
NCT05510544 Dec 2022 → Dec 2023 lymphoma Peking University
Unknown
No outcome recorded
Phase 4
NCT05087212 Oct 2021 → Dec 2022 disease related to hematopoietic stem cell transplant Sanofi
Completed
No outcome recorded
Phase 4
NCT02006225 Feb 2014 → Feb 2019 disease related to hematopoietic stem cell transplant Tel-Aviv Sourasky Medical Center
Unknown
No outcome recorded
Phase 4
NCT01164475 Oct 2010 → Feb 2013 non-Hodgkin lymphoma Genzyme, a Sanofi Company
Completed
Missed primary
Phase not applicable 4 trials
— NCT01408043 Oct 2011 → May 2016 Burkitt lymphoma , MALT lymphoma , T-cell large granular lymphocyte leukemia , Waldenstrom macroglobulinemia +18 Case Comprehensive Cancer Center
Terminated
No outcome recorded
Stop: Enrollment
— NCT01076270 Jun 2010 → Jan 2011 Burkitt lymphoma , Hodgkins lymphoma , MALT lymphoma , acute myeloid leukemia with 11q23 abnormalities +19 Fred Hutchinson Cancer Center
Terminated
No outcome recorded
Stop: Business
— NCT01186224 May 2010 → Jun 2015 lymphoproliferative syndrome , plasma cell myeloma University of Liverpool
Completed
No outcome recorded
— NCT01042717 Feb 2010 → Dec 2011 non-Hodgkin lymphoma , plasma cell myeloma Shi, Patricia, M.D.
Unknown
No outcome recorded
Comparator or background therapy 34 trials
Phase 1
NCT06506461 Background Mar 2025 → Dec 2029 expected sickle cell disease St. Jude Children's Research Hospital
Recruiting
No outcome recorded
Phase 1
NCT04418414 Background Sep 2024 → Aug 2029 expected hemophilia A Expression Therapeutics, LLC
Not yet recruiting
No outcome recorded
Phase 1
NCT06414889 Background May 2024 → Jun 2027 expected hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 M.D. Anderson Cancer Center
Recruiting
No outcome recorded
Phase 1
NCT05088356 Background Sep 2021 → May 2028 expected acute leukemia , chronic myeloid leukemia , disease related to hematopoietic stem cell transplant , myelodysplastic syndrome Stanford University
Active not recruiting
No outcome recorded
Phase 1
NCT03506802 Background Jul 2018 → Jun 2019 plasma cell myeloma Jonsson Comprehensive Cancer Center
Withdrawn
No outcome recorded
Stop: Enrollment
Phase 1
NCT03240861 Background Jul 2017 → Oct 2023 high grade malignant neoplasm , sarcoma Jonsson Comprehensive Cancer Center
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT02343666 Background Aug 2016 → Aug 2020 HIV infectious disease , Hodgkins lymphoma , non-Hodgkin lymphoma Fred Hutchinson Cancer Center
Withdrawn
No outcome recorded
Stop: Enrollment
Phase 1
NCT02750254 Background Jun 2016 → May 2017 acute lymphoblastic leukemia , acute myeloid leukemia , myelodysplastic syndrome Washington University School of Medicine
Terminated
No outcome recorded
Stop: Enrollment
Phase 1
NCT01802892 Background Nov 2012 → Apr 2013 —
GlaxoSmithKline
Completed
No outcome recorded
Phase 1
NCT01331018 Background Feb 2012 → Feb 2024 Fanconi anemia Fred Hutchinson Cancer Center
Terminated
No outcome recorded
Stop: Business
Phase 1
NCT01526096 Background Jul 2011 → Aug 2024 plasma cell myeloma University of Chicago
Completed
No outcome recorded
Phase 1
NCT01352650 Comparator Jun 2011 → Dec 2016 acute myeloid leukemia Weill Medical College of Cornell University
Completed
No outcome recorded
Phase 1
NCT00943943 Background Oct 2010 → Mar 2017 acute myeloid leukemia M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 1/2
NCT07775313 Background Oct 2026 → Dec 2031 expected WHIM syndrome , dysgammaglobulinemia , myeloid hemopathy , skin disorder caused by infection National Institute of Allergy and Infectious Diseases (NIAID)
Enrolling by invitation
No outcome recorded
Phase 1/2
NCT06851767 Background May 2025 → Dec 2034 expected T-B+ severe combined immunodeficiency due to gamma chain deficiency National Institute of Allergy and Infectious Diseases (NIAID)
Enrolling by invitation
No outcome recorded
Phase 1/2
NCT06158828 Background Nov 2024 → Sep 2028 expected acute myeloid leukemia by FAB classification , childhood acute myeloid leukemia Washington University School of Medicine
Recruiting
No outcome recorded
Phase 1/2
NCT06325709 Background Apr 2024 → Dec 2032 expected granulomatous disease, chronic, X-linked National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
No outcome recorded
Phase 1/2
NCT05357482 Background May 2022 → Jan 2026 overdue beta thalassemia , sickle cell disease National Heart, Lung, and Blood Institute (NHLBI)
Active not recruiting
No outcome recorded
Phase 1/2
NCT03653247 Background Mar 2019 → Jul 2025 sickle cell disease Sangamo Therapeutics
Completed
No outcome recorded
Phase 1/2
NCT03157804 Background Jan 2016 → Apr 2019 Fanconi anemia Hospital Infantil Universitario Niño Jesús, Madrid, Spain
Completed
Met primary
Phase 1/2
NCT01318317 Background Oct 2011 → Oct 2013 overdue mantle cell lymphoma City of Hope Medical Center
Active not recruiting
No outcome recorded
Phase 1/2
NCT00669669 Background Feb 2009 → Jul 2018 gliosarcoma Fred Hutchinson Cancer Center
Terminated
No outcome recorded
Stop: Business
Phase 2
NCT07605416 Background Apr 2027 → Nov 2032 expected plasma cell leukemia National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 2
NCT06207799 Background Jul 2024 → Dec 2029 expected plasma cell myeloma M.D. Anderson Cancer Center
Recruiting
No outcome recorded
Phase 2
NCT02682953 Background Oct 2015 → Feb 2017 plasma cell myeloma University of Maryland, Baltimore
Withdrawn
No outcome recorded
Stop: Enrollment
Phase 2
NCT02570542 Background Oct 2015 → Oct 2026 expected diffuse large B-cell lymphoma Memorial Sloan Kettering Cancer Center
Active not recruiting
No outcome recorded
Phase 2
NCT02098109 Background Aug 2014 → Jun 2016 non-Hodgkin lymphoma , plasma cell myeloma Washington University School of Medicine
Completed
No outcome recorded
Phase 2
NCT01746173 Background Jul 2013 → Oct 2014 T-cell non-Hodgkin lymphoma Dana-Farber Cancer Institute
Terminated
No outcome recorded
Stop: Enrollment
Phase 2
NCT01621477 Background Aug 2012 → Dec 2015 acute lymphoblastic leukemia , chronic myeloid leukemia , juvenile myelomonocytic leukemia , myelodysplastic syndrome +1 St. Jude Children's Research Hospital
Terminated
No outcome recorded
Phase 2
NCT01403896 Comparator Apr 2012 → Dec 2015 lymphoma Stephen Couban
Completed
No outcome recorded
Phase 2
NCT01413100 Background Sep 2011 → Sep 2023 systemic sclerosis Fred Hutchinson Cancer Center
Completed
No outcome recorded
Phase 2/3
NCT02231879 Comparator Oct 2014 → Oct 2020 dysgammaglobulinemia , myeloid hemopathy , neutropenia , viral infectious disease National Institute of Allergy and Infectious Diseases (NIAID)
Completed
No outcome recorded
Phase 3
NCT04000698 Background Oct 2019 → Jul 2022 acute lymphoblastic leukemia , acute myeloid leukemia Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Unknown
No outcome recorded
— NCT00720603 Background — Hodgkins lymphoma , non-Hodgkin lymphoma , plasma cell myeloma Genzyme, a Sanofi Company
No longer available
No outcome recorded
Show 29 more trials